BLCONYQHealthcare·Medical Instruments & Supplies#13 in industry

Bausch + Lomb Corporation

Reports in 2d· 2026-04-29

-5.7% · 90d

$15.88

+0.06 (+0.38%)

After-Hours $15.88(+0.00)

News

(1)

April 2026

Apr 10, 20262 weeks agoDEF 14AHealthcare

Bausch & Lomb Shareholders Vote on Executive Pay and Board

BLCOBausch & Lomb Corp

# 🧾 What This Document Is This is Bausch + Lomb's official "Proxy Statement." Think of it as the company's annual homework assignment for its shareholders. Before the yearly meeting, the company must tell owners (shareholders) what decisions need to be made and provide the information they need to

Read summaryView on SEC EDGAR

Key Data

Market Cap$5.66B

Open$15.80

Prev Close$15.82

Day Range$15.84 – $16.23

52W Range$10.45 – $18.91

Volume372,869

P/E (TTM)—

EPS$-1.02

Dividend Yield—

Beta0.65

Profit Margin-7.06%

Revenue Growth9.80%

Price Target$18.35(+15.5%)

Next Earnings2026-04-29(2d)

Analyst Ratings

Buy14 analysts

Buy 4Hold 9Sell 1

About

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provide optical correction during healing. It also offers contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. The Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.

Healthcare · Medical Instruments & Supplies

13,000 employees

www.bausch.com